Addex Therapeutics Ltd
SIX:ADXN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Addex Therapeutics Ltd
SIX:ADXN
|
CH |
|
Soliton Systems KK
TSE:3040
|
JP |
|
IPH Ltd
F:1IP
|
AU |
|
C
|
Cummins Inc
XMUN:CUM
|
US |
|
Tesmec SpA
F:2GV
|
IT |
|
Teleperformance SE
PAR:TEP
|
FR |
|
CareCloud Inc
F:MTB0
|
US |
Intrinsic Value
Is ADXN undervalued or overvalued?
See the intrinsic value estimate for Addex Therapeutics Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Addex Therapeutics Does
Addex Therapeutics is a drug development company focused on medicines that act on G protein-coupled receptors, especially through a method called allosteric modulation. In plain English, it tries to make small-molecule drugs that fine-tune how receptors in the brain and body work, rather than simply switching them on or off. Its main work is centered on treatments for nervous system and inflammatory diseases, where receptor control can affect symptoms and disease pathways.
- Headquarters
- Switzerland CH
- Employees
- 3
- IPO date
- May 22, 2007
Revenue & Expenses Breakdown
Addex Therapeutics Ltd
Earnings Waterfall
Addex Therapeutics Ltd
The intrinsic value for Addex Therapeutics Ltd (ADXN) under the Base Case is hidden CHF.
Compared with the current market price of 0.0226 CHF, the stock appears hidden.